p51/p63, a novel p53 homologue, potentiates p53 activity and is a human cancer gene therapy candidate

Journal of Gene Medicine

Volumn 8, Issue 9, 2006, Pages 1121-1130

  Kunisaki, Reiko ^a,b   Ikawa, Shuntaro ^c   Maeda, Toyoki ^d   Nakazaki, Yukoh ^d   Kurita, Ryo ^d   Harata, Masamitsu ^a   Shutoh, Yukinobu ^a   Bai, Yuang Sung ^a   Soda, Yasushi ^a   Tanabe, Tsuyoshi ^a   Dohi, Taeko ^e   Kato, Rie ^e   Ikawa, Yoji ^f   Asano, Shigetaka ^a   Tani, Kenzaburo ^d  

^a UNIVERSITY OF TOKYO   (Japan)

^b YOKOHAMA CITY UNIVERSITY   (Japan)

^c TOHOKU UNIVERSITY   (Japan)

^d KYUSHU UNIVERSITY   (Japan)

^e NATIONAL CENTER FOR GLOBAL HEALTH AND MEDICINE   (Japan)

^f TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Np51; Adenovirus vector; Apoptosis; p51; p53 family; Tumor suppressor

Indexed keywords

ADENOVIRUS VECTOR; BETA GALACTOSIDASE; COMPLEMENTARY DNA; PROTEIN P51A; PROTEIN P53; PROTEIN P63; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER THERAPY; CARCINOGENESIS; DRUG POTENTIATION; FEMALE; GENE OVEREXPRESSION; GENE SEQUENCE; GENE TARGETING; GENETIC TRANSDUCTION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LUNG CANCER; MITOSIS INHIBITION; MOUSE; NONHUMAN; NONVIRAL GENE THERAPY; NUCLEOTIDE SEQUENCE; PANCREAS CANCER; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; STOMACH CANCER; TUMOR SUPPRESSOR GENE; UPREGULATION; VIRAL GENE DELIVERY SYSTEM;

ADENOVIRIDAE; ANIMALS; APOPTOSIS; BASE SEQUENCE; CELL ADHESION; CELL LINE, TUMOR; CELL PROLIFERATION; COLONY-FORMING UNITS ASSAY; DNA PRIMERS; DNA-BINDING PROTEINS; FEMALE; GENE THERAPY; GENES, P53; GENETIC VECTORS; HUMANS; LAC OPERON; LUNG NEOPLASMS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; NEOPLASMS; PANCREATIC NEOPLASMS; STOMACH NEOPLASMS; TRANS-ACTIVATORS; TRANSDUCTION, GENETIC; TRANSPLANTATION, HETEROLOGOUS; TUMOR SUPPRESSOR PROTEINS;

ADENOVIRIDAE;

EID: 33749248025     PISSN: 1099498X     EISSN: 15212254     Source Type: Journal    
DOI: 10.1002/jgm.945     Document Type: Article

References (26)

1. Levine AJ. p53, a cellular gatekeeper for growth and division. Cell 1997; 88: 323-331.
2. Wang XW, Harris CC. p53 tumor-suppressor gene: clues to molecular carcinogenesis. J Cell Physiol 1997; 173: 247-255.
3. Kaghad M, Bonnet H, Yang A, et al. Monoallelically expressed gene related to p53 at 1p36, a region frequently deleted in neuroblastoma and human cancers. Cell 1997; 90: 809-819.
4. Osada M, Ohba M, Kawahara C, et al. Cloning and functional analysis of human p51, which structurally and functionally resembles p53. Nat Med 1998; 4: 839-843.
5. Shimada A, Kato S, Enjo K, et al. The transcriptional activities of p53 and its homologue p51/p63: similarities and differences. Cancer Res 1999; 59: 2781-2786.
6. Yang A, Schweitzer R, Sun D, et al. p63 is essential for regenerative proliferation in limb, craniofacial and epithelial developmant. Nature 1999; 398: 714-718.
7. Sunahara M, Shishikura T, Takahashi M, et al. Mutational analysis of p51A/TAp63γ, a p53 homolog, in non-small cell lung cancer and breast cancer. Oncogene 1999; 18: 3761-3765.
8. Tani M, Shimizu K, Kawahara C, et al. Mutation and expression of the p51 gene in human lung cancer. Neoplasia 1999; 1: 71-79.
9. Ishida S, Yamashita T, Nakaya U, Tokino T. Adenovirus-mediated transfer of p53-related genes induces apoptosis of human cancer cells. Jpn J Cancer Res 2000; 91: 174-180.
10. Senoo M, Matsumura Y, Habu S. TAp63gamma (p51A) and dNp63alpha (p73L), two major isoforms of the p63 gene, exert opposite effects on the vascular endothelial growth factor (VEGF) gene expression. Oncogene 2002; 21: 2455-2465.
11. Yang A, Kaghad M, Wang Y, et al. p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell 1998; 2: 305-316.
12. Katoh I, Aisaki KI, Kurata SI, Ikawa S, Ikawa Y. p51A(TAπ63γ), a p53 homolog, accumulates in response to DNA damage for cell regulation. Oncogene 2000; 19: 3126-3130.
13. Celli J, Duijf P, Hamel BC, et al. Heterozygous germline mutations in the p53 homolog p63 are the cause of EEC syndrome. Cell 1999; 99: 143-153.
14. Senoo M, Tsuchiya I, Matsumura Y, et al. Transcriptional dysregulation of the p73L/p63/p51/p40/KET gene in human squamous cell carcinomas: expression of ΔNp73L, a novel dominant-negative isoform, and loss of expression of the potential tumor suppressor. Br J Cancer 2001; 84: 1235-1241.
15. Ikawa S, Nakagawara A, Ikawa Y. p53 family genes: structural comparison, expression and mutation. Cell Death Differ 1999; 6: 1154-1161.
16. Sasaki Y, Morimoto I, Ishida S, Yamashita T, Imai K, Tokino T. Adenovirus-mediated transfer of the p53 family genes, p73 and p51/p63 induces cell cycle arrest and apoptosis In colorectal cancer cell lines: potential application to gene therapy of colorectal cancer. Gene Ther 2001; 8: 1401-1408.
17. Miyake S., Makimura M., Kanegae Y, et al. Efficient generation of recombinant adenovirus using adenovirus DNA-terminal protein complex and a cosmid bearing full length virus genome. Proc Natl Acad Sci U S A 1991; 93: 1320-1324.
18. Graham FL, Prevec L. Manipulation of adeno-virus vectors. Gene transfer and expression protocols. In Methods in Molecular Biology, Murray EJ (ed). The Humana Press: Clifton, 1991; 109-128.
19. Fukayama M, Kanno T, Brody SL, Kirby M, Crystal RG. Respiratory tract gene transfer: transplantation of genetically modified T lymphocytes directory to the respiratory epithelial surface. J Biol Chem 1991; 266: 18339-18344.
20. Carollo M, Parente L, D'Alessandro N. Dexamethasone-induced cytotoxic activity and drug resistance effects in androgen-independent prostate tumor PC-3 cells are mediated by lipocortin 1. Oncol Res 1998; 10: 245-254.
21. Carlsson G, Gullberg B, Hafstrom L. Estimation of liver tumor volume using different formulas - an experimental study in rats. J Cancer Res Clin Oncol 1983; 105: 20-23.
22. Naruse I, Keino H, Kawarada Y. Antibody against single-stranded DNA detects both programmed cell death and drug-induced apoptosis. Histochemistry 1994; 101: 73-78.
23. Welander CE, Morgan TM, Homesley HD, Trotta PP, Spiegel RJ. Combined recombinant human interferon alpha 2 and cytotoxic agents studied in a clonogenic assay. Int J Cancer 1985; 35: 721-729.
24. Sasaki Y, Ishida S, Morimoto I, et al. The p53 family member genes are involved in the Notch signal pathway. J Biol Chem 2002; 277: 719-724.
25. Dai Y, Schwarz EM, Gu D, Zhang WW, Sarvetnick N, Verma IM. Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor LX and vector antigens allows for long-term expression. Proc Natl Acad Sci U S A 1995; 92: 1401-1405.
26. Rosenfeld MA, Yoshimura K, Trapnell BC, et al. In vivo transfer of the human cystic fibrosis transmembrane conductance regulator gene to the airway epithelium. Cell 1992; 68: 143-155.